PRAX

Praxis Precision Medicines
PRAX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$875.87M
EV
$404.91M
Shares Outstanding
20.37M
Beta
2.63

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$97.67
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Praxis Precision Medicines, Inc.

gainify
PRAX

Praxis Precision Medicines, Inc.

PRAX

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhi...

Sector

Healthcare

Industry

Biotechnology

CEO

De'Souza, Marcio

Employees

116

IPO Date

2020-10-16

Headquarters

99 High Street, 30th Floor, Boston, Massachusetts, 02110, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.